Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$27,000.00
The role of G6PD in breast cancer metastasis: Insights into G6PD inhibition as a therapeutic strategy.
FY 2024-25
Summary
Breast cancer (BCa) is the leading cause of cancer and cancer death among women. A challenge in BCa treatment is metastasis, responsible for most breast cancer fatalities. Recently, a key role for altered cellular metabolism has been demonstrated in cancer. Glucose-6-phosphate dehydrogenase (G6PD) the rate-limiting enzyme in the pentose phosphate pathway (PPP), converts glucose-6-phosphate to 6-phosphogluconolactone while reducing NADP+ to NADPH. This leads to production of ribulose-5-phosphate, which is the foundation for synthesis of nucleotide precursors that are in high demand in rapidly dividing cancer cells. Produced NADPH also counteracts reactive oxygen species generated in cancer cells. Thus, G6PD helps tumor cells overcome stress and supports their metabolic demands, which may promote metastatic tumor growth as a result. It was suggested that high G6PD expression in BCa patients is associated with poor prognosis, however its role in BCa progression requires further assessment. I hypothesize G6PD aids cancer cells to adapt to stress in metastatic sites and its inhibition can impede growth. My research objectives are to establish the role of G6PD activity in overcoming cell stress by testing if its inhibition enhances apoptosis in response to chemotherapy, or other cellular stresses, and determine if G6PD inhibition impairs metastatic tumor phenotypes in vitro and in vivo. As some studies and clinical trials using G6PD inhibitors have shown promising anticancer effects and increased chemosensitivity in other cancer types, I aim to establish that inhibition of G6PD can represent a new strategy for metastatic BCa treatment.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
530203
Name
Guo Sabrina
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of G6PD in breast cancer metastasis: Insights into G6PD inhibition as a therapeutic strategy.
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Breast Cancer Treatment; Cancer; Cell Stress; Drug Therapy; G6pd; G6pd Inhibition; Invasion; Metastasis; Tumours
Abstract
Breast cancer (BCa) is the leading cause of cancer and cancer death among women. A challenge in BCa treatment is metastasis, responsible for most breast cancer fatalities. Recently, a key role for altered cellular metabolism has been demonstrated in cancer. Glucose-6-phosphate dehydrogenase (G6PD) the rate-limiting enzyme in the pentose phosphate pathway (PPP), converts glucose-6-phosphate to 6-phosphogluconolactone while reducing NADP+ to NADPH. This leads to production of ribulose-5-phosphate, which is the foundation for synthesis of nucleotide precursors that are in high demand in rapidly dividing cancer cells. Produced NADPH also counteracts reactive oxygen species generated in cancer cells. Thus, G6PD helps tumor cells overcome stress and supports their metabolic demands, which may promote metastatic tumor growth as a result. It was suggested that high G6PD expression in BCa patients is associated with poor prognosis, however its role in BCa progression requires further assessment. I hypothesize G6PD aids cancer cells to adapt to stress in metastatic sites and its inhibition can impede growth. My research objectives are to establish the role of G6PD activity in overcoming cell stress by testing if its inhibition enhances apoptosis in response to chemotherapy, or other cellular stresses, and determine if G6PD inhibition impairs metastatic tumor phenotypes in vitro and in vivo. As some studies and clinical trials using G6PD inhibitors have shown promising anticancer effects and increased chemosensitivity in other cancer types, I aim to establish that inhibition of G6PD can represent a new strategy for metastatic BCa treatment.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Guo, Sabrina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~